BIOMAT Database Logo BIOMAT Database Logo

Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. 2006

R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Antibody-mediated rejection (AMR) after liver transplantation is recognized in ABO incompatible and xeno-transplantation, but its role after ABO compatible liver transplantation is controversial. We report a case of ABO compatible liver transplantation that demonstrated clinical, serological and histological signs of AMR without evidence of concurrent acute cellular rejection. AMR with persistently high titers of circulating donor specific antibodies resulted in graft injury with initial centrilobular hepatocyte necrosis, fibroedematous portal expansion mimicking biliary tract outflow obstruction, ultimately resulting in extensive bridging fibrosis. Immunofluorescence microscopy demonstrated persistent, diffuse linear C4d deposits along sinusoids and central veins. Despite intense therapeutic intervention including plasmapheresis, IVIG and rituximab, AMR led to graft failure. We present evidence that an antibody-mediated alloresponse to an ABO compatible liver graft can cause significant graft injury independent of acute cellular rejection. AMR shows distinct histologic changes including a characteristic staining profile for C4d.

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
October 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.
March 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
ABO-compatible retransplantation after ABO-incompatible infant heart transplantation: absence of donor specific isohemagglutinins.
December 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
ABO-compatible liver allograft antibody-mediated rejection: an update.
June 2015, Current opinion in organ transplantation,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Histological long-term outcomes from acute antibody-mediated rejection following ABO-compatible liver transplantation.
April 2017, Journal of gastroenterology and hepatology,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation.
July 2009, World journal of gastroenterology,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Variability in donor-specific alloantibody production after transplantation.
November 2007, Transplantation proceedings,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Potential effect of using ABO-compatible living-donor liver transplantation.
November 2009, Transplantation proceedings,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: "Liaisons dangereuses"?
June 2019, Transplant immunology,
R Watson, and T Kozlowski, and V Nickeleit, and J T Woosley, and J L Schmitz, and S L Zacks, and J H Fair, and D A Gerber, and K A Andreoni
Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation.
February 2016, The British journal of surgery,
Copied contents to your clipboard!